Share Name Share Symbol Market Type Share ISIN Share Description
Akers Biosciences, Inc LSE:AKR London Ordinary Share US00973E1029 COM SHS NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 162.50p 160.00p 165.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 1.4 -6.5 -122.8 - 8.83

Akers Biosciences Share Discussion Threads

Showing 3701 to 3722 of 3725 messages
Chat Pages: 149  148  147  146  145  144  143  142  141  140  139  138  Older
DateSubjectAuthorDiscuss
05/12/2016
09:17
"Noddy" = puerileRamridge - if you want to respond to post 3326 then please feel free. Otherwise, best wishes with your investments.
wigwammer
04/12/2016
15:02
Well done. You corrected the spelling.Its a start.
wigwammer
04/12/2016
09:18
"Npddy" You certainly missed something
wigwammer
04/12/2016
06:46
Noddy You still miss the point
norbus
02/12/2016
13:48
Ramridge - one is a monitoring device, the other is a disposable test. Management clearly believe the product has a unique place and potential, and Alere (a multi billion usd multinational) appears to agree with them. "A nod is as good as a wink to a blind horse.." I nodded at 90p, ta ta now.
wigwammer
02/12/2016
12:44
Exactly ramridge and mcm's point Remember a wink is as good as a nod to a blind horse, There will be all sorts of gymnastics but the program will end flat on the floor.
norbus
02/12/2016
12:40
wigwammer - Here is an extract from yesterday's RNS " Akers Bio's Tri-Cholesterol "Check" test is the only combined rapid test which provides an estimate of a person's Total cholesterol as well as their High Density Lipoprotein ("HDL") cholesterol levels - their 'good cholesterol'; thereby providing an estimate of a person's Low Density Lipoprotein ("LDL") levels - their 'bad cholesterol'. These features are essential to accurately differentiating between a person's 'good' and 'bad' cholesterol thereby making it a truly effective screening test for high cholesterol. " Well, that is a blatant lie. It is not the only such product in the market. A few minutes of googling providing me with information about quite a few others in the market able to analyse to the same degree. Below is just one example: " Cholesterol Home Test: The one name that comes up most often for home cholesterol tests is CardioChek. They have the more scientific looking devices that sell for over $100 and promise clinically accurate results. Their blood analyzers do score better in tests than the less expensive paper strips without an electronic device to analyze them. The top rated CardioChek Home Blood Analyzer # 730, 1 ea is one that we found listed all over the Internet. Not all owner reviews are positive, but it did more praise than other systems. The device uses color coded PTS PANELS test strips that get inserted into the machine and you get a readout for Total Cholesterol, HDL Cholesterol, Triglycerides, Glucose and Ketone. The digital display will give you the details usually after 1 to 2 minutes of analysis. You get 2 test strips in the package along with 2 AAA batteries that it requires to run. " My point is this. As a result of management putting out this blatant lie (at best management is incompetent if they were not aware of such competing products, or at worse deliberately misleading the public), the share price spiked yesterday to as much as 255p before crashing. Go tell the guys who bought on the news that this is not important but HIT, etc is . This is misleading the market in a serious way that should not go unpunished.
ramridge
02/12/2016
12:21
Yes, you can't point to any hype because it isn't there.Let's re-CAP: i purchased my shares below 100p and you suggested this was a mistake. The shares then rallied 100%+ and you changed your story and became more positive. Now the shares have fallen back somewhat you turn negative again.So you have proven more of a commentator than a sage, and certainly haven't provided me with anything of use (i'm up around 60-70% here).Ramridge - I don't think anyone owns the stock for the tri-cholesterol product. I had forgotten it existed tbh. The point that a multi billion usd outfit thinks it is worth giving it another go is a small positive, but nonetheless a positive. The positions in HIT, oxidative stress and now chlamydia are of far more interest. Imho dyor
wigwammer
02/12/2016
12:08
You, wigwammer, and a couple of others have tried to put a rose tint on the glass and a gloss that is not there. go back to your own post. ramridge if correct about competitors , may have called curtains
norbus
02/12/2016
11:29
ramridge a man after my own heart; The UN is the only organisation worse than controllers of AIM and humbler markets; AKR is on NASDAQ which makes the misinformation shocking. mcm did a great job toning down invalid hype here. If I lost money, I would go to NASDAQ and report the scam.
norbus
02/12/2016
11:10
I was interested in buying a few shares yesterday so did a bit of googling to validate the claims made and see if there are competitors. Well, not only are there many competitors but quite a few also offer tests which cover both good and bad cholesterol readings. This company's claim that their product is unique in offering a comprehensive set of cholesterol readings is balloney and a lot of tosh. Today's post by mcmather that they were trying to flog the same 8 years ago is shocking. I think this company is run by con artists and I really feel for the punters who bought the story yesterday and are now looking at a major loss. Shame on the advisors and brokers who support such blatant pickpocketing by rogue management.
ramridge
02/12/2016
09:19
very illiquid stock this one...as can be seen by the recent seller who just sold 2697 shares today whioh were bought yesterday at around £1200 loss!!
pre
01/12/2016
23:29
Aye. And if they had managed to sell the (same) Tri-Cholesterol devices for the past 8 years, those admittedly abysmal HIT sales would likely have avoided Wally squandering $15m worth of funds on who knows what.
mcmather
01/12/2016
20:09
If they can replicate the abysmal sales achieved by the HIT test with any of the other products then we have a company that covers its op costs. Any sales beyond that - 70% falls to the bottom line.
wigwammer
01/12/2016
19:38
Aye, but this one also sounded promising. 8 years ago... "Akers Biosciences, Inc, a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that it has signed an agreement with a large U.S. distributor specialising in over-the-counter diagnostic products. The distributor, who cannot be named for commercial reasons, will market several of the Company's products to the U.S. retail market, including Tri-Cholesterol, the only disposable, rapid test in the world to read HDL, LDL and Total cholesterol levels. Marketing of ABI's products under the agreement will begin immediately to drug, food and convenience stores and mass retailers. Clients include such retailers as Kmart, Wal-Mart, CVS, Walgreens, 7-Eleven, Safeway, Costco and Target". http://uk.advfn.com/stock-market/london/akers-biosciences-AKR/share-news/U-S-Over-the-Counter-Distribution-Agreement/29417227
mcmather
01/12/2016
18:52
Yes appears "genuine" good news for a change.Nice.
algernon2
01/12/2016
12:06
Well, well...this sounds rather exciting. Worth noting in particular that First Check are a subsidiary of the mighty Alere Inc.... Http://www.investegate.co.uk/akers-biosciences--akr-/rns/us-distribution-agreement--cholesterol-self-test/201612011200066905Q/ "Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, has signed a distribution agreement with First Check Diagnostics, LLC ("First Check"), the major global diagnostic device and service provider, to serve as the exclusive distributor of the Company's rapid cholesterol self-test in the United States under their "First Check" brand. First Check products are sold through major retailers including, CVS, Rite Aid, Target, Kmart, Meijer, Giant Eagle, Stop & Shop, Giant and ShopKo. Akers Bio's Tri-Cholesterol "Check" test is the only combined rapid test which provides an estimate of a person's Total cholesterol as well as their High Density Lipoprotein ("HDL") cholesterol levels - their 'good cholesterol'; thereby providing an estimate of a person's Low Density Lipoprotein ("LDL") levels - their 'bad cholesterol'. These features are essential to accurately differentiating between a person's 'good' and 'bad' cholesterol thereby making it a truly effective screening test for high cholesterol. etc"
rivaldo
30/11/2016
08:53
Ever since our Raymond lost his goat , he discovered a new way of milking
norbus
29/11/2016
17:18
Heard it before with alcoholic breathalyzers etc etc etc
werewolfie
28/11/2016
08:38
Been there, done that, what's new? If these tests which are not cheap, had any real merit in the real world, they would be flying off the shelf; I guess Raymond could be inventing problems for the solutions
norbus
28/11/2016
07:17
Interesting
gersemi
18/11/2016
08:29
I suspect placing at $2, but I doubt it will be offered to aim holders.The $88k pw figure was for 9m16 ie historic. Forward annualised breakeven point $4.6m revenues. So assuming just the $2.5m US hit sales and 65% gross margin implies cash shortfall of $1.35m pa or $26k pw.$88k to $26k pw = step change in costs.
wigwammer
Chat Pages: 149  148  147  146  145  144  143  142  141  140  139  138  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20161208 07:51:14